Literature DB >> 18325082

Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database.

S E A Leigh1, A H Foster, R A Whittall, C S Hubbart, S E Humphries.   

Abstract

Familial hypercholesterolemia (FH) (OMIM 143890) is most commonly caused by variations in the LDLR gene which encodes the receptor for Low Density Lipoprotein (LDL) cholesterol particles. We have updated the University College London (UCL) LDLR FH database (http://www.ucl.ac.uk/ldlr) by adding variants reported in the literature since 2001, converting existing entries to standard nomenclature, and transferring the database to the Leiden Open Source Variation Database (LOVD) platform. As of July 2007 the database listed 1066 unique LDLR gene events. Sixty five percent (n = 689) of the variants are DNA substitutions, 24% (n = 260) small DNA rearrangements (<100bp) and 11% (n = 117) large DNA rearrangements (>100bp), proportions which are similar to those reported in the 2001 database (n = 683, 62%, 24% and 14% respectively). The DNA substitutions and small rearrangements occur along the length of the gene, with 24 in the promoter region, 86 in intronic sequences and 839 in the exons (93 nonsense variants, 499 missense variants and 247 small rearrangements). These occur in all exons, with the highest proportion (20%) in exon 4 (186/949); this exon is the largest and codes for the critical ligand binding region, where any missense variant is likely to be pathogenic. Using the PolyPhen and SIFT prediction computer programmes 87% of the missense variants are predicted to have a deleterious effect on LDLR activity, and it is probable that at least 48% of the remainder are also pathogenic, but their role in FH causation requires confirmation by in vitro or family studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325082     DOI: 10.1111/j.1469-1809.2008.00436.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  75 in total

1.  Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptor.

Authors:  Siham El Aziz; Asma Chadli; Hassan El Ghomari; Ahmed Farouqi
Journal:  BMJ Case Rep       Date:  2012-05-23

Review 2.  Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics.

Authors:  Christopher C Imes; Melissa A Austin
Journal:  Biol Res Nurs       Date:  2012-04-23       Impact factor: 2.522

3.  Tumor necrosis factor beta NcoI polymorphism (rs909253) is associated with inflammatory and metabolic markers in acute ischemic stroke.

Authors:  Johnathan de Sousa Parreira; Ana Paula Kallaur; Marcio Francisco Lehmann; Sayonara Rangel Oliveira; Daniela Frizon Alfieri; Daniela Alfieri Frizon; Francieli Delongui; Franceili Delongui; Maria Caroline Martins de Araújo; Carolina Rossato; Jessica Tavares de Almeida; Larissa Muliterno Pelegrino; Erick Frank Bragato; Helena Kaminami Morimoto; Andrea Name Colado Simão; Damacio Ramon Kaimen-Maciel; Edna Maria Vissoci Reiche
Journal:  Metab Brain Dis       Date:  2014-07-27       Impact factor: 3.584

4.  Exome sequencing in suspected monogenic dyslipidemias.

Authors:  Nathan O Stitziel; Gina M Peloso; Marianne Abifadel; Angelo B Cefalu; Sigrid Fouchier; M Mahdi Motazacker; Hayato Tada; Daniel B Larach; Zuhier Awan; Jorge F Haller; Clive R Pullinger; Mathilde Varret; Jean-Pierre Rabès; Davide Noto; Patrizia Tarugi; Masa-Aki Kawashiri; Atsushi Nohara; Masakazu Yamagishi; Marjorie Risman; Rahul Deo; Isabelle Ruel; Jay Shendure; Deborah A Nickerson; James G Wilson; Stephen S Rich; Namrata Gupta; Deborah N Farlow; Benjamin M Neale; Mark J Daly; John P Kane; Mason W Freeman; Jacques Genest; Daniel J Rader; Hiroshi Mabuchi; John J P Kastelein; G Kees Hovingh; Maurizio R Averna; Stacey Gabriel; Catherine Boileau; Sekar Kathiresan
Journal:  Circ Cardiovasc Genet       Date:  2015-01-27

5.  Efficient TALEN-mediated gene knockout in livestock.

Authors:  Daniel F Carlson; Wenfang Tan; Simon G Lillico; Dana Stverakova; Chris Proudfoot; Michelle Christian; Daniel F Voytas; Charles R Long; C Bruce A Whitelaw; Scott C Fahrenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

6.  Low prevalence of mutations in known loci for autosomal dominant hypercholesterolemia in a multiethnic patient cohort.

Authors:  Zahid Ahmad; Beverley Adams-Huet; Chiyuan Chen; Abhimanyu Garg
Journal:  Circ Cardiovasc Genet       Date:  2012-10-11

7.  Incomplete knowledge of the clinical context as a barrier to interpreting incidental genetic research findings.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

Review 8.  Novel Therapies for Familial Hypercholesterolemia.

Authors:  Justin Parizo; Ashish Sarraju; Joshua W Knowles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-11

9.  Hypercholesterolemia and microvascular dysfunction: interventional strategies.

Authors:  Phoebe A Stapleton; Adam G Goodwill; Milinda E James; Robert W Brock; Jefferson C Frisbee
Journal:  J Inflamm (Lond)       Date:  2010-11-18       Impact factor: 4.981

10.  An integrated approach to the interpretation of single amino acid polymorphisms within the framework of CATH and Gene3D.

Authors:  Jose M G Izarzugaza; Anja Baresic; Lisa E M McMillan; Corin Yeats; Andrew B Clegg; Christine A Orengo; Andrew C R Martin; Alfonso Valencia
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.